Abstracts tagged "MACE"

Abstract Number: 846 • ACR/ARP Annual Meeting 2019
MACE and VTE Across Multiple Upadacitinib Studies in Rheumatoid Arthritis: Integrated Analysis from the SELECT Phase 3 Clinical Program
Ernest Choy¹, Iain McInnes ², John Cush ³, Jacob Aelion ⁴, Ying Zhang ⁵, Nasser Khan ⁶, Jianzhong Liu ⁶, Heidi Camp ⁷, Sebastian Meerwein ⁸, William Rigby ⁹ and Alexander Cohen ¹⁰, ¹Cardiff University School of Medicine, Cardiff, United Kingdom, ²Institute of Infection, Immunity & Inflammation, University of Glasgow, Glasgow, United Kingdom, ³5Baylor University Medical Center, Dallas, ⁴Arthritis Clinic PLLC, Jackson, ⁵AbbVie Inc., North Chicago, IL, USA, North Chicago, IL, ⁶Abbvie Inc, North Chicago, IL, ⁷AbbVie Inc., North Chicago, IL, ⁸AbbVie GmbH Co. KG, Ludwigshafen, Germany, Wiesbaden, Germany, ⁹Dartmouth-Hitchcock Medical Center, Lebanon, ¹⁰Guy’s and St Thomas’ NHS FT Hospitals, King’s College London, London, United Kingdom
Background/Purpose: Patients (pts) with RA have an approximate 2-fold increased risk of cardiovascular (CV) morbidity and mortality and of venous thromboembolic events (VTE)1,2. Among RA…